首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical cancer research

缩写:CLIN CANCER RES

ISSN:1078-0432

e-ISSN:1557-3265

IF/分区:10.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11950条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Arathi Mohan,Kent A Griffith,Laura W Goff et al. Arathi Mohan et al.
Purpose: This phase 2 trial investigated rucaparib (PARP inhibitor) in combination with nivolumab in patients with advanced BTC without progression after 4-6 months of first-line platinum-based chemotherapy. ...
Ferdinandos Skoulidis,Salma K Jabbour,Edward B Garon et al. Ferdinandos Skoulidis et al.
Purpose: POSEIDON (NCT03164616) was a randomized, open-label, multicenter phase 3 trial comparing first-line durvalumab with or without tremelimumab in combination with chemotherapy versus chemotherapy alone in patients w...
Jia Liu,Max Farrow,Sandra S Hsing et al. Jia Liu et al.
Purpose: Access to early-phase clinical trials (EPCTs) is increasingly constrained by delays in genomic testing and lack of coordinated system-level navigation. The New South Wales Early Phase Clinical Trials Alliance (NE...
Kasidy Brown,Noah I Hornick,Megan K Ruhland Kasidy Brown
The ability of an individual's immune system to mount a productive response against the tumor is critical for the success of immunotherapy. Clinical trials in multiple tumor types have revealed that the degree and way in which any one perso...
Douglas V Faget,Rachel E Brewer,Joseane Sampaio et al. Douglas V Faget et al.
Purpose: CD24 is a "don't eat me" signal overexpressed across multiple solid tumors and contributes to immune evasion by suppressing macrophage-mediated phagocytosis. Targeting the CD24/Siglec-10 axis represents a novel i...
Kevin Charles Miller,Teng Fei,Ruben J Faustino Ramos et al. Kevin Charles Miller et al.
Purpose: Lenalidomide is integral to multiple myeloma therapy, but long-term use is frequently complicated by diarrhea, which diminishes patient quality-of-life. The pathophysiology of lenalidomide-related diarrhea (LRD) ...
Sriram Sridhar,Guy Roukens,Christina Y Yu et al. Sriram Sridhar et al.
Purpose: Tisotumab vedotin (TV) is a tissue factor (TF)-specific antibody-drug conjugate that was evaluated in the innovaTV 204 study in patients with recurrent or metastatic cervical cancer (r/mCC). Although TF expressio...
Wenjuan Dong,Shiruo Wang,Bill Chan et al. Wenjuan Dong et al.
Purpose: Trastuzumab deruxtecan (T-DXd) has improved outcomes in metastatic breast cancer; however, a substantial subset of patients experience early lack of clinical benefit that is not reliably predicted by routine clin...